Vitamin D3 and other nutrients in the Premenstrual Sindrome treatment

被引:0
|
作者
Molteni, E. [1 ]
Cioni, F. [2 ]
机构
[1] Osped Desio, UO Ginecol, Milan, Italy
[2] Univ Parma, Azienda Osped, Serv Malattie Ricambio & Diabetol, I-43100 Parma, Italy
来源
PROGRESS IN NUTRITION | 2008年 / 10卷 / 04期
关键词
Premenstrual syndrome; vitamin D-3; calcium;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The premenstrual syndrome is a disorder very common in fertile women, especially in the third decade of life. It seems that the trigger is the hormonal changes in the body, but there are also unknown causes. It occurs from 10 to 14 days before menstruation, include mental disorders as bad mood, tension and irritability, and physical disorders such as fluid retention, abdominal sense of tension and, in cases pu severe pain itself. Among the causes of premenstrual syndrome today is given great importance to nutritional factors such as the proper intake of vitamin D and calcium diet; in a recent study, in fact, it was shown that adequate dietary calcium combined with proper supplementation of vitamin D is efficacious in the treatment and prevention of this disorder.
引用
收藏
页码:203 / 209
页数:7
相关论文
共 50 条
  • [21] Vitamin D3 metabolites and analogues in the treatment of scalp psoriasis
    Langner, A
    Stapor, W
    Ambroziak, M
    JOURNAL OF DERMATOLOGICAL TREATMENT, 1998, 9 : 41 - 45
  • [22] Nutritional status and vitamin D3 during antimicrobial treatment
    Warmelink, Ina
    van Altena, Richard
    ten Hacken, Nick
    van der Werf, Tjip
    van der Veer, Eveline
    LANCET, 2011, 377 (9775): : 1407 - 1408
  • [23] Bioavailability of alendronate and Vitamin D3 in an alendronate/Vitamin D3 combination tablet.
    Lazarus, N.
    Porras, A.
    Constanzer, M.
    Woolf, E.
    Maganti, L.
    Wagner, J. A.
    Gottesdiener, K.
    Denker, A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S307 - S307
  • [24] Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment
    Braun, Gerald S.
    Witt, Matthias
    Mayer, Verena
    Schmid, Holger
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2007, 46 (12) : 1315 - 1317
  • [25] ANTIPROLIFERATIVE ACTIVITY OF TAMOXIFEN, VITAMIN D3 AND THEIR CONCOMITANT TREATMENT
    Yetkin, Derya
    Balli, Ebru
    Ayaz, Furkan
    EXCLI JOURNAL, 2021, 20 : 1394 - 1406
  • [26] Mechanism of action of vitamin D3 analogues in the treatment of psoriasis
    Tiberio, R
    Bozzo, C
    Guenzi, C
    Pertusi, G
    Leigheb, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : A76 - A76
  • [27] Tissue content of vitamin D3 and 25-hydroxy vitamin D3 in minipigs after cutaneous synthesis, supplementation and deprivation of vitamin D3
    Burild, Anders
    Frandsen, Henrik Lauritz
    Poulsen, Morten
    Jakobsen, Jette
    STEROIDS, 2015, 98 : 72 - 79
  • [28] Changes in 25-Hydroxyvitamin D3 to oral treatment with vitamin D3 in postmenopausal females with osteoporosis
    Hoeck, H. C.
    Li, B.
    Qvist, P.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (08) : 1329 - 1335
  • [29] Vitamin D3 and 25(OH)D3: an open debate
    Minisola, Salvatore
    De Martino, Viviana
    Cipriani, Cristiana
    Pepe, Jessica
    Colangelo, Luciano
    Sonato, Chiara
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2021, 114 (03): : 1251 - 1251
  • [30] Changes in 25-Hydroxyvitamin D3 to oral treatment with vitamin D3 in postmenopausal females with osteoporosis
    H. C. Hoeck
    B. Li
    P. Qvist
    Osteoporosis International, 2009, 20